Shandong Weihai’s Hidden Champions
From Weihai, Shandong, comes a hidden champion: Weigao Blood Purification. Its core business is blood purification, providing medical devices and pharmaceuticals needed for treatment in end-stage renal disease patients—such as hemodialyzers, hemodialysis machines, and peritoneal dialysis solutions.
In 2021, Weigao’s revenue reached RMB 2.91 billion, growing to RMB 3.42 billion in 2022, up 17.71% year on year; revenue further increased to RMB 3.53 billion in 2023, a 3.09% year-on-year rise.
Hemodialyzers accounted for 51.31% of main business revenue. In the hemodialyzer and hemodialysis circuit markets, Weigao’s market shares were 32.5% and 32.8%, respectively, with relatively stable main business revenue.